Pakistan; Saudi Arabia; Algeria; Libya; Egypt; Oman; India; Tunisia; China
Ingredient ID: NPC82374
Ingredient ID: NPC7349
Ingredient ID: NPC71074
Ingredient ID: NPC68160
Ingredient ID: NPC65133
Ingredient ID: NPC61779
Ingredient ID: NPC51700
Ingredient ID: NPC49457
Ingredient ID: NPC48623
Ingredient ID: NPC469781
Ingredient ID: NPC469770
Ingredient ID: NPC469769
Ingredient ID: NPC469759
Ingredient ID: NPC4574
Ingredient ID: NPC36061
Ingredient ID: NPC34672
Ingredient ID: NPC34550
Ingredient ID: NPC330326
Ingredient ID: NPC32021
Ingredient ID: NPC311295
Ingredient ID: NPC31032
Ingredient ID: NPC306386
Ingredient ID: NPC305835
Ingredient ID: NPC30395
Ingredient ID: NPC303511
Ingredient ID: NPC301585
Ingredient ID: NPC29883
Ingredient ID: NPC290598
Ingredient ID: NPC289021
Ingredient ID: NPC285231
Ingredient ID: NPC282773
Ingredient ID: NPC280076
Ingredient ID: NPC279121
Ingredient ID: NPC27765
Ingredient ID: NPC272804
Ingredient ID: NPC27184
Ingredient ID: NPC269888
Ingredient ID: NPC264317
Ingredient ID: NPC261831
Ingredient ID: NPC260837
Ingredient ID: NPC25495
Ingredient ID: NPC243728
Ingredient ID: NPC239051
Ingredient ID: NPC228614
Ingredient ID: NPC224684
Ingredient ID: NPC220210
Ingredient ID: NPC219809
Ingredient ID: NPC217922
Ingredient ID: NPC21568
Ingredient ID: NPC212315
Ingredient ID: NPC209970
Ingredient ID: NPC209846
Ingredient ID: NPC209232
Ingredient ID: NPC20511
Ingredient ID: NPC203719
Ingredient ID: NPC195458
Ingredient ID: NPC195334
Ingredient ID: NPC192638
Ingredient ID: NPC18772
Ingredient ID: NPC17839
Ingredient ID: NPC178104
Ingredient ID: NPC176300
Ingredient ID: NPC171736
Ingredient ID: NPC165967
Ingredient ID: NPC165003
Ingredient ID: NPC162973
Ingredient ID: NPC162168
Ingredient ID: NPC160261
Ingredient ID: NPC158088
Ingredient ID: NPC121158
Ingredient ID: NPC115798
Ingredient ID: NPC113733
Ingredient ID: NPC100980
Ingredient ID: NPC10005
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Therapeutic Target | Enzyme | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Therapeutic Target | Enzyme | CES1 | Acyl coenzyme A:cholesterol acyltransferase | P23141 | CHEMBL2265 |
Therapeutic Target | Fatty acid binding protein family | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Therapeutic Target | Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Therapeutic Target | Metallo protease | MMP12 | Matrix metalloproteinase 12 | P39900 | CHEMBL4393 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Therapeutic Target | Oxidoreductase | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | P28845 | CHEMBL4235 |
Therapeutic Target | Protein Kinase | MKNK2 | MAP kinase signal-integrating kinase 2 | Q9HBH9 | CHEMBL4204 |
Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Therapeutic Target | Protein Kinase | MKNK1 | MAP kinase-interacting serine/threonine-protein kinase MNK1 | Q9BUB5 | CHEMBL4718 |
Therapeutic Target | Serine protease | DPP4 | Dipeptidyl peptidase IV | P27487 | CHEMBL284 |
Therapeutic Target | Small molecule receptor (family A GPCR) | DRD1 | Dopamine D1 receptor | P21728 | CHEMBL2056 |
Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Therapeutic Target | Transcription factor | RELA | Nuclear factor NF-kappa-B p65 subunit | Q04206 | CHEMBL5533 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 95 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT03474198 | Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00396084 | Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01119521 | Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02821832 | Using Biomarkers to Predict TB Treatment Duration | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02563327 | Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT05454345 | Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01516203 | Phase 2a EBA Trial of AZD5847 | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | prostate cancer | Ursolic Acid (NPC51700) | NP level |
NCT00351702 | Preventive Therapy for Tuberculosis in HIV Infected Persons | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01223534 | QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00130247 | Tuberculosis Treatment Shortening Trial | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02043314 | A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00701987 | Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma | melanoma | Betulinic Acid (NPC264317) | NP level |
NCT00966836 | Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy | cytomegalovirus infection | Phenol (NPC100980) | NP level |
NCT03891901 | A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00638196 | Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS | multiple sclerosis | Oleic Acid (NPC261831) | NP level |
NCT02342886 | Shortening Treatment by Advancing Novel Drugs | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00001033 | The Treatment of Tuberculosis in HIV-Infected Patients | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00330304 | Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00144417 | TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00402454 | Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis | HIV infection | Isoniazid (NPC330326) | NP level |
NCT04311502 | Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT03474029 | Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT04272242 | Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals | HIV infection | Isoniazid (NPC330326) | NP level |
NCT02256696 | Assessing PA-824 for Tuberculosis (the APT Trial) | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT03028129 | Prevention of Tuberculosis in Prisons | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00000778 | A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02409290 | The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02337933 | Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome | metabolic syndrome | Ursolic Acid (NPC51700) | NP level |
NCT00495326 | Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) | AIDS;tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02454205 | An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis | multidrug-resistant tuberculosis | Isoniazid (NPC330326) | NP level |
NCT05473195 | A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01154959 | Latency in Pulmonary Tuberculosis | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02457208 | PK Study of Anti-TB Drugs | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00571753 | Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2) | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00931736 | Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01782950 | Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00140309 | TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02208427 | Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00346502 | Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia) | dysplastic nevus | Betulinic Acid (NPC264317) | NP level |
NCT02099240 | Patients Response to Early Switch To Oral:Osteomyelitis Study | osteomyelitis | Isoniazid (NPC330326) | NP level |
NCT01197040 | Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome | nephrotic syndrome | Phenol (NPC100980) | NP level |
NCT03334734 | Phase 2a Study of PBTZ169 | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02236078 | Brief Bactericidal Activity of Anti-Tuberculosis Drugs | drug-resistant tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00128206 | Treatment of Latent TB Infection for Jailed Persons | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00513396 | High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02613169 | Infant TB Infection Prevention Study | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00057122 | Tuberculosis Prevention for HIV Infected Adults | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00864383 | Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00023452 | Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00170209 | Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02958709 | Optimizing Treatment to Improve TBM Outcomes in Children | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT04504851 | Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02735590 | The Correlate of Risk Targeted Intervention Study | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT05124678 | Pharmacogenetics-guided Isoniazid Dosing in TB-HIV | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01589497 | Essentiality of INH in TB Therapy | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02651259 | Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01582711 | Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT03216876 | A Study Of Ursolic Acid For Primary Sclerosing Cholangitis | sclerosing cholangitis | Ursolic Acid (NPC51700) | NP level |
NCT00816426 | Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT04094012 | Risk of SDRs Under 3HP and 1HP Regimen for LTBI | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00376012 | Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00317330 | A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00042289 | Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy | HIV infection | Isoniazid (NPC330326) | NP level |
NCT03444298 | A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults | asthma;inflammation | (2R)-2,7,8-Trimethyl-2-[(4R,8R)-4,8,12-Trimethyltridecyl]-3,4-Dihydrochromen-6-Ol (NPC48623) | NP level |
NCT00164463 | TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT03568383 | Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT04485156 | Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02467608 | Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01825031 | Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy | HIV infection | Isoniazid (NPC330326) | NP level |
NCT02581527 | A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02279875 | A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001) | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01792310 | A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours | glioma | Oleic Acid (NPC261831) | NP level |
NCT01398618 | Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI) | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00397709 | Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02901288 | Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01838200 | Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma | metastatic melanoma | Isoniazid (NPC330326) | NP level |
NCT00767975 | Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00298870 | Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02193776 | A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00728507 | Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT02331823 | Research on New Regimens for Retreatment Pulmonary Tuberculosis | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT04802928 | Healing of Ischemic Leg Ulcers in Patients Treated With iSONIAzid | ulcer disease | Isoniazid (NPC330326) | NP level |
NCT01785186 | Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01989897 | Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests | allergic rhinitis | Phenol (NPC100980) | NP level |
NCT01380080 | REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment | HIV infection | Isoniazid (NPC330326) | NP level |
NCT03730181 | Tuberculosis Clinical Trials Consortium Study 35 | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00023335 | TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis | pulmonary tuberculosis | Isoniazid (NPC330326) | NP level |
NCT00004736 | Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis | HIV infection | Isoniazid (NPC330326) | NP level |
NCT00933790 | Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01661764 | Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention | colorectal adenoma | Oleic Acid (NPC261831) | NP level |
NCT01342497 | Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study | diabetic foot | Isoniazid (NPC330326) | NP level |
NCT01936831 | High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) | tuberculosis | Isoniazid (NPC330326) | NP level |
NCT01468415 | Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs | Back pain | Phenol (NPC100980) | NP level |
NCT05383742 | Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis | meningitis | Isoniazid (NPC330326) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CA7,CES1,DPP4,RECQL,XDH,DRD1,CYP1B1,HSD11B1,HIF1A
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CSNK2A2,MMP12,CA7,DPP4,CA12,RECQL,XDH,FLT3,DRD1
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
FABP4,NOX4,MMP12,FABP5,CA12,CA4,MMP12,TRIM24,CA12
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
NOX4,AKR1B1,DPP4,FABP5,CA12,XDH,CA4,DRD1,HIF1A
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
NOX4,MMP12,CSNK2A3,FABP5,CA12,CYP1A2,XDH,RORC
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
FABP4,NOX4,MMP12,AKR1B1,FABP5,CA12,TRIM24,CA4
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
MMP12,AKR1B1,DPP4,FABP5,FLT3,TRIM24,DRD1,CYP1B1
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
MMP12,CA7,AKR1B1,DPP4,FABP5,XDH,RORC
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
NOX4,MMP12,CSNK2A3,AKR1B1,FABP5,CA4,HIF1A
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
NOX4,MMP12,CA7,DPP4,CA12,XDH,CYP1B1
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
NOX4,MMP12,CA7,DPP4,FABP5,CA12,CA4
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
RORC,DPP4,RELA,FLT3
MMP12,FABP5 |
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT01380080,NCT00004736,NCT00402454,NCT01825031,NCT04272242,NCT00042289
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
NOX4,MMP12,FABP5,XDH,CA4,RORC
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
NCT00816426,NCT02958709,NCT02342886,NCT00396084,NCT03474029,NCT01785186,NCT00495326,NCT02651259,NCT02457208,NCT00140309,NCT00767975,NCT00317330,NCT00933790,NCT00397709,NCT00351702,NCT00376012,NCT02613169,NCT02563327,NCT05124678,NCT00023452,NCT00000778,NCT02901288,NCT04311502,NCT00330304,NCT03334734,NCT02735590,NCT00057122,NCT01589497,NCT02043314,NCT00513396,NCT01782950,NCT04094012,NCT01516203,NCT01398618,NCT02409290,NCT01936831,NCT00128206,NCT00130247,NCT00144417,NCT03568383,NCT00170209,NCT04485156,NCT00728507,NCT03474198,NCT00931736,NCT01582711,NCT03730181,NCT05454345,NCT00001033,NCT03891901,NCT00164463,NCT03028129,NCT02193776,NCT01223534,NCT01119521,NCT02208427
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
NOX4,MMP12,AKR1B1,DPP4,FLT3
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
CSNK2A3,DPP4,FABP5,CA12,CYP1B1
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
PPARA,HSD11B1,DPP4,AKR1B1
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
PPARA,DPP4,RELA,HSD11B1
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
MKNK1,MKNK2,FLT3
NCT01661764 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
CA4,CA12,MKNK2,MKNK1
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
FABP5,XDH,MMP12,FABP5
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
MMP12,CA7,CA12,XDH
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
MMP12,CA7,CA12,XDH
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
NOX4,DPP4,CYP1B1,HSD11B1
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
RORC,RELA
NCT00638196 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
GSK3B,FLT3,RELA
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
RORC,MMP12,FLT3
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
MKNK2,HIF1A,MKNK1
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
MKNK1,CSNK2A1,MKNK2
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
HSD11B1,DPP4
NCT02337933 |
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
DPP4,PPARA,RELA
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
HSD11B1,CA4,AKR1B1
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
RORC
HSD11B1,MMP12 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
CA4,MMP12
NCT03444298 |
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
CES1,PPARA,HSD11B1
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
NOX4,HSD11B1,MMP12
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
NOX4,MMP12,DRD1
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
FABP4,NOX4,MMP12
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NOX4,MMP12,CYP1A1
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
MMP12,CA12,XDH
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
MMP12,CYP1A1,XDH
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CA12,CYP1A1,CYP1A2
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH,PPARA
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
HSD11B1,FLT3
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
DRD1,AKR1B1
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
GSK3B,FLT3
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
DPP4,FLT3
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
PPARA
FABP4 |
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
RELA,AKR1B1
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
DRD1,HIF1A
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA12,CA4
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
HSD11B1,XDH
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA4,CA12
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
DRD1,GSK3B
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
DPP4,CES1
|
NADisease Category: NADisease ICD-11 Code: NA |
NOX4
NCT03444298 |
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
PPARA,HSD11B1
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
HSD11B1,RELA
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
CA4,RORC
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
MMP12,DPP4
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
DPP4,CA4
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NOX4,MMP12
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
AKR1B1,CYP1A2
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
FABP4,NOX4
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NOX4,FABP5
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
MMP12,CYP1A1
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
XDH,HIF1A
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
MMP12,CA12
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
NOX4,MMP12
|
Tuberculosis of the respiratory systemDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10 |
NCT02821832,NCT01154959,NCT02581527,NCT00571753,NCT05473195,NCT00864383,NCT02467608,NCT00023335,NCT00298870,NCT02331823,NCT02256696,NCT02279875,NCT04504851
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
CA4,RELA,MKNK1,RORC,FLT3,CSNK2A1,MKNK2,GSK3B,XDH,HIF1A,CA12,PPARA
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
CSNK2A2,FABP4,NOX4,AKR1B1,FABP5,CA12,RECQL,PPARA,TRIM24,HSD11B1
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
XDH
|
Tic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A05 |
DRD1
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
FLT3
|
Autoimmune diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40-4A45 |
RORC
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
DPP4
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH
|
Synthesis disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52-5C59 |
CES1
|
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
DRD1
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
FLT3
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RELA
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
AKR1B1
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
AKR1B1
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
RELA
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
FLT3
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
FLT3
|
AbortionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA00 |
DRD1
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
FLT3
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
RELA
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
HSD11B1
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
HIF1A
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
DRD1
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
PPARA
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
FLT3
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
DRD1
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
FLT3
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
FLT3
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
AKR1B1
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
FLT3
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
AKR1B1
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
RELA
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
HIF1A
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
RELA
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
HSD11B1
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
DRD1
|
Peroxisomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C57 |
CES1
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
FLT3
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
RELA
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MMP12
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
GSK3B
|
Fragile X chromosomeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD55 |
GSK3B
|
Myotonic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71 |
GSK3B
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
RELA
|
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3
|
HyperlipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PPARA
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
DPP4
|
DyslipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80-5C81 |
PPARA
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
FLT3
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
RELA
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT04403568
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
NCT01468415
|
Congenital cytomegalovirus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.3 |
NCT00966836
|
Nephritic syndromeDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB40 |
NCT01197040
|
Dysplastic naevusDisease Category: X.Extension CodesDisease ICD-11 Code: XH9035 |
NCT00346502
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT00495326
|
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
NCT01989897
|
Osteomyelitis or osteitisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB84 |
NCT02099240
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT01792310
|
Multi-drug resistant Mycobacterium tuberculosisDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG52.00 |
NCT02236078
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NCT00701987
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT01838200
|
TuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B12 |
NCT02454205
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
NCT01342497
|
Primary sclerosing cholangitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.2 |
NCT03216876
|
ulcer diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61-DA63.Y |
NCT04802928
|
Other specified infectious meningitis not elsewhere classifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.Y |
NCT05383742
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CYP1A1
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CA12
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
MMP12
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1
|
Malignant neoplasms of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
FABP4
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
CA4
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
DPP4
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA4
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOX4
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
CYP1A1
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
CYP1A1
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
FABP4
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
MMP12
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FLT3
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
FABP4
|